Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)
Sponsor: Merck Sharp & Dohme LLC
Summary
The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD). Before giving a trial medicine to people with a health condition, researchers first do clinical trials in healthy people. This trial will help researchers learn about the safety of MK-1403 and if participants tolerate it. Tolerate means participants receive the trial medicine and they do not need to stop taking it due to health problems. The trial will also measure what happens to MK 1403 in a healthy person's body over time.
Official title: A Clinical Study to Evaluate the Relative Bioavailability of MK-1403 Formulations Administered to Healthy Adult Participants
Key Details
Gender
All
Age Range
18 Years - 55 Years
Study Type
INTERVENTIONAL
Enrollment
15
Start Date
2026-07-29
Completion Date
2026-09-22
Last Updated
2026-06-30
Healthy Volunteers
Yes
Conditions
Interventions
MK-1403 formulation (FM) 1 + additive
Oral tablet
MK-1403 FM2 + additive
Oral tablet